Neurocrine Bioscience buy Cantor Fitzgerald
Start price
13.09.23
/
50%
€107.25
Target price
13.09.24
€126.70
Performance (%)
18.32%
Price
10.05.24
€126.90
Summary
This prediction is currently active. The prediction currently has a performance of 18.32%. This prediction currently runs until 13.09.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | -2.907% | -2.907% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $136.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.55
10.04.24
10.04.24
€144.01
10.04.25
10.04.25
-2.05%
10.05.24
10.05.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€102.55
24.10.23
24.10.23
-
24.10.24
24.10.24
27.50%
10.05.24
10.05.24